Carmell Therapeutics (CTCX) - 2022 Q4 - Annual Report
Carmell Therapeutics (CTCX)2023-03-17 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-40228 Alpha Healthcare Acquisition Corp. III (Exact name of Registrant as specified in its charter) Delaware 85-1645738 (State or Ot ...